Results 41 to 50 of about 88,672,115 (295)

Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo. [PDF]

open access: yesPLoS ONE, 2014
Lymphocyte Activation Gene - 3 (LAG-3) is an immune checkpoint molecule that regulates both T-cell activation and homeostasis. However, the molecular mechanisms underlying LAG-3's function are generally unknown.
Nicholas M Durham   +6 more
doaj   +1 more source

Bone Marrow Lymphocyte Subpopulation in Chronic Lymphocytic Leukemia Patients with Different Responses to Chemotherapy

open access: yesКлиническая онкогематология
AIM. To analyze the bone marrow lymphocyte subpopulation based on targeted assessment of PD-1, PD-L1, and LAG-3 marker expression in chronic lymphocytic leukemia (CLL) patients with different responses to chemotherapy. MATERIALS & METHODS.
Olesya Nikolaevna Selyutina   +7 more
doaj   +1 more source

Modulation of CTLA-4, STAT3 and LAG-3 Expression by Ibrutinib and Idelalisib in Leukemic Cells of Patients with Chronic Lymphocytic Leukemia [PDF]

open access: yesMiddle East Journal of Cancer
Background: Small molecule inhibitors are the new therapeutic approaches for many cancers, but their exact mechanisms in tumor evasion and expansion remains unknown.
Fatemeh Mousavi-Mirkalaei   +9 more
doaj   +1 more source

Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation. [PDF]

open access: yesPLoS ONE, 2014
Lag-3 has emerged as an important molecule in T cell biology. We investigated the role of Lag-3 in conventional T cell (Tcon) and regulatory T cell (Treg) function in murine GVHD with the hypothesis that Lag-3 engagement diminishes alloreactive T cell ...
Emanuela I Sega   +5 more
doaj   +1 more source

LAG‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics

open access: yesCancer Medicine, 2023
Background Lymphocyte activation gene 3 (LAG‐3) or CD223 is a transmembrane protein that serves as an immune checkpoint which attenuates T‐cell activation.
Jacob J. Adashek   +11 more
doaj   +1 more source

Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization

open access: yesFrontiers in Immunology, 2021
BackgroundTransarterial chemoembolization (TACE) stands for the most commonly utilized therapy for hepatocellular carcinoma (HCC) worldwide. This study was to explore the potential predictive and prognostic roles of LAG-3 and PD-L1 as serum biomarkers in
Mengzhou Guo   +7 more
doaj   +1 more source

lag-1_EMBD0068_MS

open access: yes, 2019
lag ...
Ronald Biggs (7851473)   +21 more
core   +1 more source

LAG-1 applied to an example visual search problem.

open access: yes, 2022
A) Visual Field input array recreated from [53]. B) An example trial of LAG-1’s visual search scan path. Each frame is centered at the successive fixation location until the target is foveated.
Mark R. Blair (11846177)   +3 more
core   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari   +5 more
wiley   +1 more source

lag-1_EMBD0068_GLS

open access: yes, 2019
lag ...
Ronald Biggs (7851473)   +21 more
core   +1 more source

Home - About - Disclaimer - Privacy